Related Experiment Video
Updated: Aug 5, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
[Diabetic nephropathy]
Roland Edlinger1, Martin Auinger, Rudolf Prager
1Medizinische Abteilung, Krankenhaus der Stadt Wien-Lainz, Wien, Osterreich.
Abstract:
Diabetes mellitus is the leading single cause for renal replacement therapy. Its development and progression, however, can be ameliorated by adequate therapy. The present article represents the recommendations of the Austrian Diabetes Association for the prevention and treatment of diabetic nephropathy.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy
